31/07/25 Instem Limited acquired Xybion Digital Inc. from Banerjee Group LLC and others. CI
15/10/24 Xybion Announces Release of New and Improved Web-Based Saas Preclinical Lims Platform: Pristima Web 10.0 CI
08/10/24 Xybion Digital Inc. Launches Xybion Lims 10.0: A Modern Saas Lims Bringing Improved Functionalities and Efficiencies for Allabs Across Industries CI
16/04/24 Envol Biomedical selects Xybion?s Preclinical Gold Standard LIMS, Pristima, to Digitize Lab Operations CI
23/02/24 Xybion Digital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
22/11/23 Xybion Digital Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
16/11/23 Xybion Digital Closes Purchase of Autoscribe, US$15 Million Credit Facility MT
16/11/23 Xybion Digital Inc. Announces USD 15 Million Credit Facility CI
16/10/23 Xybion Digital Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
16/10/23 Xybion Digital Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
14/09/23 Deciphex and Xybion Digital Inc. Join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows CI
08/08/23 Certara, Inc. and Xybion Digital Inc. Partner to Integrate Nonclinical R&D Software to Streamline Assessing Drug Safety & Efficacy CI
30/05/23 Xybion to Streamline, Digitize and Optimize Stability Study Operations and Improve Compliance Using Labwise XD LIMS Platform CI
Manager TitleAgeSince
Chief Executive Officer - 15/11/2021
Director of Finance/CFO - 15/11/2021
President - 15/11/2021
Director TitleAgeSince
Director/Board Member 68 15/11/2021
Chairman - 15/11/2021
Director/Board Member - 15/11/2021
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%+4.65% - - 34.45M
-0.12%+2.08%+7.17%+49.42% 3,980B
+3.74%-12.16%-7.61%+772.28% 373B
+0.52%-10.15%-51.84%+7.60% 359B
+1.22%-12.81%+50.92%+169.20% 257B
-2.75%-0.62%-3.67%+63.11% 279B
+1.86%-11.66%+66.18%+373.79% 223B
-0.38%-3.12%-40.71%-16.42% 106B
-2.61%-4.66%-27.12%-57.81% 95.91B
-1.42%-11.18%+50.06%+141.24% 90.01B
Average +0.07%-10.92%+4.82%+166.93% 640.43B
Weighted average by Cap. -0.06%-3.31%+5.46%+110.63%
Logo XYBN DIGI
Xybion Digital Inc. is a software as a service company, which digitizes drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a cloud platform. It offers solution through Pristima XD, Labwise XD, Xybion QMS, Emidence XD, and ECM XD. Its solutions focus on employee health and safety, integrated preclinical lab management, early-stage drug discovery, digital lab solutions, regulatory compliance, quality management, predictive compliance, content management, and systems validation. The Company help its customers with cloud-enabled Laboratory Information Management System (LIMS) software with embedded document management, data management, compliance, and safety modules. It serves industries, such as life sciences, healthcare and insurance, safety and workers comp, transportation, financial services, food and beverage, manufacturing, petrochemicals, radio pharmacy, biobanking, veterinary sciences, and materials and mining, among others.
Employees
-
  1. Stock Market
  2. Stocks
  3. XYBN Stock